New Insights on PMR Treatments

This chapter delves into a Bachelor study assessing the effectiveness of baricitinib compared to placebo for newly diagnosed polymyalgia rheumatica (PMR). The discussion highlights skepticism around methotrexate for treating PMR and Giant Cell Arteritis, emphasizing the need for tailored treatment strategies and more robust studies to improve patient management.